Search

everythinglearnresearchcommunity

for

Search:↓

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

Combining irinotecan and cetuximab is effective for some metastatic colorectal cancer patients but often causes manageable skin issues.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

Ayurveda-based care may improve quality of life for breast cancer patients without serious side effects.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Clinical trials should use innovative designs and biomarkers to improve precision therapy and patient outcomes.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Oral dutasteride, minoxidil, and finasteride may help reduce hair loss in breast cancer survivors, but more research is needed.

The patient showed tumor stability and improved health using a new Periwinkle preparation with chemotherapy.

Some existing medicines show promise as safe treatments to protect against the side effects of radiation therapy.

The combination therapy was effective and well-tolerated, especially in young patients.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Tamoxifen effectively treats gynecomastia without causing impotence.

For better medication adherence in benign prostatic hyperplasia treatment, tamsulosin and finasteride should be packaged together and taken at the same time.

Combination therapy for BPH is more effective in certain men but may not be cost-effective due to minimal impact and potential side effects.

Combination therapy is more effective for prostate volumes over 60 ml.

Different prostate cancer treatments have similar risks of secondary cancers and related mortality when considering patient age and smoking history.

Alfuzosin reduces short-term surgery need after catheter removal, but long-term benefits are unclear; combination therapy may help prevent urinary issues.

The combined treatment helped prevent hair loss and promoted full hair regrowth in breast cancer patients after chemotherapy.

Partial hair-sparing brain radiotherapy is possible and doesn't affect cancer control but still causes noticeable hair loss.

Low-dose oral minoxidil combined with topical minoxidil improves hair growth in breast cancer patients with therapy-induced hair loss.